PMID int64 27.8M 36.2M | Title/Abstract stringlengths 7 10.7k | MeshTerms stringlengths 7 104 | SemanticTypes stringlengths 4 84 |
|---|---|---|---|
34,674,629 | consensus base ensembl approach improv transcriptom assembl system level analys differenti gene express analysi co express analysi metabol pathway reconstruct depend accuraci transcriptom multipl tool exist perform transcriptom assembl rnaseq data howev assembl high qualiti transcriptom still trivial problem especi case non model organ adequ refer genom often avail differ method produc differ transcriptom model easi way determin accur furthermor altern splice event exacerb difficult assembl problem benchmark transcriptom assembl critic also trivial due general lack true refer transcriptom | D016678;D059467 | T086;T028;T081 |
34,674,628 | compar refer base refer free transcriptom analysi approach gene express level late high throughput rna sequenc extens use elucid transcriptom landscap dynam cell type differ speci particular non model organ lack complet refer genom high qualiti annot genet inform refer free rf de novo transcriptom analys rather refer base rb approach wide use rf analys substanti contribut toward understand mechan regul key biolog process function date numer bioinformat studi conduct assess workflow product rate complet transcriptom assembl within rf rb dataset howev degre consist variabl result obtain analyz gene express level two differ approach adequ document | D020869;D059467 | T086;T059;T063;T081 |
34,674,626 | design synthesi bioactiv evalu novel chalcon deriv possess tryptophan moieti dual activ anti cancer partial restor prolifer normal kidney cell pre treat cisplatin chalcon broad spectrum natur product anti cancer anti inflammatori activ howev low potenc low select serious side effect limit druggabl l tryptophan essenti precursor molecul anti cancer activ substanc also indol moieti inhibit prolifer tumor cell bind colchicin site decreas kidney cell activ caus kidney inflamm primari side effect cancer therapi | D000970;D002599;D047188 | T121;T109 |
34,674,625 | synthesi anticanc evalu molecular dock hexahydroquinolin deriv mcl inhibitor apoptosi induc hexahydroquinolin small molecul report good cytotox affin toward mcl henc new compound explor mcl inhibitor potent anticanc agent | D000970 | T121;T109 |
34,674,623 | assess manag loos bodi knee joint relat diseas narrat review loos bodi frequent encount clinic activ common find knee arthroscopi usual treatment consist remov loos bodi challeng even experienc surgeon excis alon alway complet treatment loos bodi general secondari diseas caus persist symptom risk new loos bodi format aim narrat review show clinic imag arthroscop evalu loos bodi order plan optim treatment | D007594;D010003 | T047;T020 |
34,674,622 | non ceruloplasmin copper stratif biomark alzheim diseas patient measur use alzheim diseas ad type dementia common elder grow bodi recent evid link ad pathogenesi copper cu dysmetabol bodi fact subset patient affect either ad prodrom form known mild cognit impair mci observ unabl maintain proper balanc cu metabol distribut character presenc serum increas level cu bound ceruloplasmin non ceruloplasmin cu sinc serum non ceruloplasmin cu biomark wilson diseas wd well known condit cu driven toxicosi review propos close analog wd assess non ceruloplasmin cu level exploit cost effect stratif susceptibilityrisk biomark identif admci individu approach also use elig criterion clinic trial aim investig cu relat intervent admci | D000544;D060825 | T048;T047 |
34,674,621 | novel probiot formula biocg protect alzheim relat cognit deficit via regul dendrit spine dynam brain gut microbiom axi emerg import pathway perturb gut andor microbi microenviron impact neurolog function alter implic varieti neuropsychiatr disord includ depress anxieti alzheim diseas ad use probiot therapi diseas remain promis howev mechan under gut microenviron influenc diseas pathogenesi therapi remain unclear | D000544;D019936 | T048;T047;T007 |
34,674,620 | toxic surfac modif dendrim critic review compar nano polym dendrim novel three dimension synthet hyperbranch nano polymer structur supramolecular dendrit structur high degre signific surfac core function transport drug target therapi specif host guest respons gene transfer therapi imag biolog system howev conflict shred evid regard biolog safeti dendrim toxic due posit charg surfac includ cytotox hemolyt toxic haematolog toxic immunogen vivo toxic surfac modif dendrim group one method resolv issu review aim investig differ strategi reduc toxic improv biocompat differ dendrim viewpoint broaden structur safe characterist dendrim biomed pharmaceut field | D050091 | T104;T122 |
34,674,617 | oppos role antimicrobi peptid skin cancer antimicrobi peptid amp also known host defens peptid ubiquit natur occur molecul secret various cell type bodi skin amp serv first line innat immun defens exogen microorgan orchestr adapt immun respons exert sever immunomodulatori function emerg evid indic amp contribut certain inflammatori skin diseas also play role skin tumor carcinogenesi avail data support hypothesi amp possess pro tumor anti neoplast properti although inconsist observ report multipl studi make challeng summar precis role amp cancer differenti express amp skin cancer increas express human beta defensin squamous cell carcinoma abil cathelicidin induc malign melanoma cell invas impli procanc activ hand observ certain amp show cytotox activ cancer cell colon kidney suggest inher antitumor properti review describ role mechan amp skin cancer develop believ research need elucid impact amp skin cancer biolog explor potenti role diagnosticprognost biomark novel therapeut target | D012878;D023083 | T191;T116 |
34,674,616 | bacteri nanocellulos base wound dress current futur prospect although mani treatment option avail wound burn dress improv technolog still requir bacteri cellulos polym deriv microbiolog world shown promis properti recommend wound heal therapeut moreov bacteri cellulos nanos form bacteri nanocellulos bnc enhanc properti import addit inher antibacteri properti bnc use deliv drug articl present bird eye view prepar method applic bnc base wound dress | D001458;D002056 | T074;T037 |
34,674,614 | mfd crossroad bacteri dna repair transcript regul molecular evolv surviv bacteria need continu evolv adapt complex environ includ may impact integr dna repositori genet inform pass futur generat multipl factor dna repair share substrat oper key cellular machineri princip replic transcript impli high degre coordin dna base activ review focus progress made understand protein factor oper crossroad three fundament process emphasi mutat frequenc declin protein mfd aka trcf although mfd research rich histori goe back time half centuri recent report hint much remain uncov argu besid transcript repair coupl factor trcf mfd also global regul transcript pro mutagen factor way interfac transcript replic nucleotid excis repair make attract candid develop strategi curb molecular evolut henc antibiot resist | D001426;D014158 | T116;T045;T123 |
34,674,612 | mir p suppress epitheli mesenchym transit tumor develop acut myeloid leukemia acut myeloid leukemia aml form primari acut leukemia high mortal previous studi demonstr mir p regul chemoresist acut leukemia cell howev biolog function mir p aml need explor | D058750;D015972 | T043;T045 |
34,674,610 | treatment acut wound hand calendula officinali l random trial injuri hand finger especi digit pulp suit heal secondari intent nevertheless delay epithel seem unfavor restrict techniqu purpos control random clinic trial analyz mean photo planimetri progress heal process secondari intent acut wound hand use standard extract calendula officinali l sec cohort elig particip includ two group patient skin loss hand finger treat secondari intent control group cg use miner oil intervent group ig receiv sec wound pictur captur outpati assess epithel achiev measur imagej intervent group ig control group cg wound primarili form men wound index ring finger left side show homogen variabl similar initi wound area epithel time shorter heal speed faster ig ig day day versus cg day day lead conclus heal secondari intent acut wound hand finger sec led faster epithel | D020838 | T002 |
34,674,609 | vivo toxicogen potenti salix alba salicacea bark extract salix alba white willow bark extract wide use condit associ inflamm fever microbi infect pain exposur human cultur leukocyt alba vitro note genotox respons howev data regard influenc bark extract dna damag vivo lack main goal studi examin potenti salba bark extract induc dna damag chromosom aberr vivo model use cell obtain male swiss albino mice administ compound oral extract administ oral gavag daili day dose mgkg bw genotox analysi perform use comet assay peripher blood leukocyt well liver bone marrow heart testicular cell collect hr last treatment micronucleus mn test bone marrow cell essenc cell collect hr penultim treatment data demonstr alba bark extract induc signific dna damag cell type examin clastogenicaneugen effect detect mn test three test dose experiment condit evid indic salba bark extract initi genotox chromosom aberr various mous cell investig | D004249 | T049 |
34,674,607 | electron note take technolog academ perform nurs student background technolog advanc provid altern tradit handwritten note take chang classroom learn environ higher educ nurs student aim purpos studi explor nurs student attitud prefer note take relationship note take method academ perform design mix method approach collect data nurs student baccalaur program studi spring fall method nurs student junior senior level academ program voluntarili particip complet survey use likert type scale open end question find major student report take note electron method signific differ found method note take gpa p conclus find suggest multipl variabl influenc learn classroom environ note take method littl impact academ perform impact statement educ consid find implement polici classroom electron includ note take understand prefer method note take whether handwritten electron littl impact overal academ perform inform evid base teach learn | D000073978;D004508;D013338 | T097;T080;T065 |
34,674,605 | address urgent global public health need strategi recov routin vaccin covid pandem routin vaccin sever impact covid pandem countri report continu disrupt vaccin servic program face challeng achiev high vaccin coverag rate vcrs well identifi vaccin miss recommend dose sinc pandem began declin vcrs even short period lead increas diseas outbreak place addit pressur health system leav communiti across world risk death diseas vaccin prevent diseasesin face disrupt select govern implement promis approach address low vcrs repres innov solut advanc short term well longer term program improv howev expand action urgent requir fulli recov vaccin program strengthen vaccin system infrastructur covid pandem provid uniqu opportun modern routin program correspond infrastructur meet today tomorrow health challeng effect effici achiev priorit routin vaccin essenti health servic improv access vaccin across life cours strengthen data system ensur sustain immun financ build confid vaccin | D000086382;D058873 | T047;T067 |
34,674,604 | monitor basal autophagi retina util cag mrfp egfp maplcb report mous technic biolog consider describ util tandem tag autophagi report mous model cag rfp egfp maplcb investig basal macroautophagicautophag flux neural retina western blot situ hybrid immunohistochemistri confoc microscopi show cag promot driven express rfp egfp maplcb increas cytosol rfp egfp lcb level wherea rfp egfp lcb ii decor true phagosom verifi electroretinograph erg respons tandem tag lcb mice compar age match control optim microscop set detect lipofuscin autofluoresc retina abca mice major retin phagosom report mice exhibit rfp egfp fluoresc suggest rapid matur phagosom total phagosom popul egfp label rfp label matur phagosom coloc lysosom marker lamp ctsd outer retina phagosom size follow ave sem rpe photoreceptor inner segment myoid outer nuclear layer detect rpe phagosom fluoresc microscopi challeng due presenc melanin increas lipofuscin autofluoresc observ abca mous model stargardt diseas strong confound factor attempt studi autophagi rpe addit rpe photoreceptor cell phagosom detect inner retin cell type microglia astrocyt endotheli cell conclud tandem tag lcb mous model serv use system studi autophagi retina util howev depend upon sever technic biolog factor includ microscop set transgen express choic fluorophor lipofuscin autofluoresc abbrevi actb actin beta aif allograft inflammatori factor atg autophagi relat ctsd cathepsin dapi diamido phenylindol dic differenti interfer contrast egfp enhanc green fluoresc protein elm extern limit membran erg electroretinographi gcl ganglion cell layer glul glutamin ammonia ligas glutamin synthetas inl inner nuclear layer em inner segment ellipsoidmyoid ish situ hybrid lamp lysosom associ membran protein li laser intens maplcb microtubul associ protein light chain beta mtor mechanist target rapamycin kinas oct optim cut temperatur os outer segment onl outer nuclear layer pe phosphatidylethanolamin rfp red fluoresc protein roi region interest rpe retin pigment epithelium | D001343;D008062 | T043;T109;T123 |
34,674,603 | pain cold heat segment puls stimul provok thermal pain illus thermal grill illus paradox pain sensat induc simultan exposur spatial separ non pain cold warm stimuli studi aim determin whether paradox sensat also evok simultan exposur pain cold heat stimuli whether mechan involv modul segment extra segment spatial integr | D007088;D017288 | T033;T048;T041 |
34,674,601 | fc gamma receptor iiib bind individu antibodi proteoform resolv affin chromatographi mass spectrometri crystalliz fragment fc immunoglobulin g igg activ key immunolog respons interact fc gamma receptor fcr fcriiib contribut neutrophil activ involv antibodi depend cellular cytotox adcc antibodi depend cellular phagocytosi adcp process present import mechan action therapeut antibodi low affin igg toward fcriiib k technic challeng interact studi addit interact strong depend igg glycosyl major contributor proteoform heterogen develop affin chromatographi mass spectrometri ac ms assay analyz igg fcriiib interact proteoform resolv manner prove well suit studi low affin interact applic select method demonstr panel nine differ igg monoclon antibodi mab includ affin low affin high affin fc engin glycoengin mab therebi could reproduc report affin rank differ igg glycosyl featur igg subclass addit post translat modif igg met oxid igg hing region glycosyl show effect fcriiib bind interest observ indic effect variabl domain sequenc fc bind deserv attent new ac ms method power tool expand knowledg structur function relationship igg fcriiib interact henc assay may substanti improv effici assess critic qualiti attribut therapeut mab respect import aspect neutrophil activ | D000920;D017452 | T043;T192;T129;T116 |
34,674,600 | n methyladenosin rna modif interact regulatori non code rnas colorect cancer one common form rna modif n methyladenosin rna modif attract increas research interest recent year revers rna modif ad new dimens post transcript regul gene express colorect cancer crc role modif extens studi mrnas also non code rnas ncrnas present review depict role modif crc systemat elabor interact modif regulatori ncrnas function mechan moreov discuss potenti applic clinic | D015972 | T045 |
34,674,597 | effect relat posit electrod stellat ganglion thermal radiofrequ ablat simul studi stellat ganglion sg block thermal radiofrequ ablat rfa frequent conduct therapeut intervent sympathet maintain neuropath pain syndrom rfa partial lack effect could part due ablat zone az complet cover sg section therefor prevent cut affer pathway object build theoret model conduct comput simul assess effect electrod posit relat sg | D017115;D000078703 | T061 |
34,674,596 | comparison uptak elimin kinet metal oxid nanomateri freshwat microcrustacean daphnia magna widespread use releas nanomateri nms aquat ecosystem concern issu well fate behavior nms relat aquat organ work freshwat microcrustacean daphnia magna expos differ well known nms condit h place clean media h order determin differ uptak elimin behavior result show test nms display fast uptak first hour arriv plateau end uptak phase elimin behavior determin fast loss nms first hour clean media main stimul presenc food remain nms concentr still found end elimin phase two nms differ profil zno nm exhibit increas loss uptak phase ii sio nm show uptak toxicokinet model appli uptak elimin rate found along dynam bioconcentr factor valu allow compar nms cluster similar rate determin tio nm one fastest uptak elimin behavior sio nm slowest uptak ceo nm slowest elimin present work repres first attempt compar differ nms base uptak elimin behavior perspect nano bio interact influenc | D049329;D014874 | T131;T073 |
34,674,592 | feasibl accept whole bodi hyperthermia wbh protocol whole bodi hyperthermia wbh shown promis non pharmacolog treatment major depress disord mdd prior trial use medic infrar hyperthermia devic evalu wbh treatment mdd howev stymi regulatori challeng | D003865;D006979 | T048;T061 |
34,674,591 | chronotyp explain daili time music behavior address circadian rhythm influenc daili music activ perform musician exhibit fine tempor control music perform often occur even late night evid suggest compos musician tend later chronotyp non compos musician howev chronotyp daili music make perform musician yet investig current studi examin chronotyp activ practic andor perform musician non musician whether relat daili time music perform test influenc daili chang due global covid pandem disrupt music athlet social sleep habit also measur perform musician activ practic non perform musician inact musician non musician resid canada complet day onlin daili activ sleep diari summer even chronotyp morn chronotyp sampl activeperform musician tend earlier chronotyp group musician chronotyp night sleep time predict time day musician made music late chronotyp made music later day earli chronotyp made music earlier day music perform practic amount decreas covid period daili time activ chang particip report later sleep onset covid period amount social interact decreas covid period exercis increas decreas other chang daili time exercis social interact morn wake report find suggest perform musician may slight earlier chronotyp non perform musician non musician despit music perform often occur even chronotyp relat time day music make independ night sleep time suggest time day make music reflect individu circadian rhythm | D000086382;D009146 | T047;T170;T067 |
34,674,590 | type calcium channel cav retinoblastoma cell regul epiderm growth factor receptor via mapk signal pathway retinoblastoma frequent intraocular cancer children also one common caus enucl carri signific morbid rate affect individu henc studi pathophysiolog growth regulatori mechan urgent need identifi effect novel therapeut | D020747;D066246;D020935;D019572;D012175 | T044;T116;T191;T123;T192;T126 |
34,674,587 | genom engin rodent status quo perspect introduct crispr cas system revolution experiment genet mice rat commentari give overview use crispr either gene edit germlin edit beyond edit somat cell futur perspect open emerg crispr technolog could enabl genom engin larger scale | D064113;D012377 | T040;T015 |
34,674,585 | metoo sexual violenc among women zambia use qualit studi involv particip aim studi investig relev metoo movement tool respond sexual violenc among women zambia find suggest rather definit establish metoo movement incontest good useless ignor cultur realiti argu critic find demonstr divers movement local view also illustr complex multidimension character zambia find thus question folli one size fit understand character metoo movement studi end provid suggest navig complex | D012742 | T048;T037 |
34,674,584 | increas neighbor intent report intim partner violenc women pandem pandem neighbor potenti alli prevent intim partner violenc women ipvaw base reason action approach identifi predictor relev belief behind neighbor intent report author woman victim ipvaw total spanish particip complet questionnair regress analysi show perceiv control subject norm best predictor intent explain varianc social media campaign target perceiv inhibitor citizen guilt report ambigu case close refer friend famili prescrib help behavior | D033182;D000066511 | T053;T041 |
34,674,583 | treat rare tumor assist expert virtual consult system two case juvenil granulosa cell tumor lack intern recogn guidelin rare tumor juvenil granulosa cell tumor jgcts nonepitheli unusu ovarian tumor challeng pediatr oncologist especi develop countri limit resourc experi treat rare tumor | D005104;D012017;D014584 | T057;T097;T170;T077;T058 |
34,674,579 | dual task accuraci respons time index effect spoken sentenc predict cognit load listen effort sequenti dual task design use assess impact spoken sentenc context cognit load listen effort young adult normal hear listen sentenc mask multitalk babbl sentenc final word either predict unpredict trial began visual present short low load long high load sequenc rememb digit word identifi quick accur predict unpredict sentenc context addit digit recal quick accur trial sentenc predict indic reduc listen effort predict compar unpredict sentenc word digit recal respons time digit recal accuraci effect predict remain signific exclus trial incorrect word respons thus independ speech intellig addit high cognit load word identifi slowli digit recal slowli less accur low load particip work memori vocabulari correl sentenc context benefit either word recognit digit recal result indic listen effort reduc sentenc predict cognit load affect process spoken word sentenc context | D000088746;D013067 | T041 |
34,674,578 | scientist ask anyth examin differ male femal scientist particip reddit ama session articl investig interact scientist onlin communiti reddit given past research comput mediat communic scientist public found male scientist typic popular onlin space femal scientist examin differ popular well potenti gender differ communic style specif examin reddit ask anyth session well comment link session n overal find male scientist receiv comment session score individu comment receiv differ gender similar find messag complex comment differ gender taken togeth suggest reddit ama session might effect platform male femal scientist engag public | D010820;D061108 | T097;T170 |
34,674,577 | curat treatment colon cancer covid pandem era coronavirus diseas covid pandem protect patient cancer reduct hospit access reduct myelosuppress risk postponingwithhold unnecessari treatment import order reduc risk infect littl known risk burden patient resect colorect cancer crc use oral chemotherapi regimen repres conveni safe manag therapi fit elder patient metastat set treatment solitari metastas may perform omit postresect chemotherapi due lack literatur data case unresect crc short induct chemotherapi follow mainten phase may improv complianc reduc toxic adjuv set shorter durat month may discuss patient except high risk case clinic judgment may reduc risk covid exposur patient crc oral regimen treatment delay chemotherapi holiday way minim global risk patient covid era | D000086382;D003110;D015179 | T191;T047;T067 |
34,674,576 | evalu intraperiton vancomycin periton dialysi associ periton intraperiton ip vancomycin recommend one treatment option gram posit coverag manag periton dialysi pd associ periton lack literatur support optim dose approach vancomycin therapeut drug level monitor | D010530;D010538 | T047;T061;T046 |
34,674,574 | effect tham nasal alkalin airway microbi communiti pilot studi non cf cf adult cystic fibrosi cf loss cftr mediat bicarbon secret reduc airway surfac liquid asl ph caus airway host defens defect aerosol sodium bicarbon revers defect effect short live aerosol tromethamin tham also rais asl ph effect much longer last pilot studi test hypothesi nasal administ tham would alter nasal bacteri composit adult without cf | D003550;D064307 | T032;T001;T047;T028 |
34,674,573 | identifi cervic cancer surviv signatur base mrna express genom wide copi number variat cervic cancer mortal second highest gynecolog cancer studi develop new model base copi number variat data mrna data overal surviv predict cervic cancer differenti express gene cancer genom atlas dataset detect univari cox regress analysi simplifi six least absolut shrinkag select oper lasso stepwis akaik inform criterion stepaic studi develop six gene signatur verifi independ dataset associ immun infiltr risk score investig immun score relat signatur function pathway examin gene set enrich analysi nineti nine differenti express gene detect corf foxp gsn hccs pgam ribc identifi key gene construct six gene signatur prognost signatur show signific correl overal surviv hazard ratio hr confid interv ci p immun score show negat correl risk score calcul signatur p four immun relat pathway close associ risk score p six gene prognost signatur effect tool predict overal surviv cervic cancer conclus newli identifi six gene may consid new drug target cervic cancer treatment | D056915 | T086;T045 |
34,674,572 | uncertain crisi time affect psychosoci dimens beta thalassemia patient covid pandem cross section studi psychosoci variabl key factor influenc delic equilibrium chronic patient crisi time studi explor distress anxieti depress loneli cope strategi chang life habit beta thalassemia patient control covid pandem patient show higher anxieti level predomin transcend cope profil compar control patient signific differ control outdoor habit social isol habit chang uncertain life threaten situat covid pandem particular detriment fragil beta thalassemia patient structur support intervent need promot well covid era | D001007;D000086382;D000079225;D017086 | T047;T184;T041;T048;T067 |
34,674,571 | lifestyl finitud inequ ill explan kathlyn conway arthur frank cancer memoir lifestyl model attribut etiolog power moral respons individu domin health promot discours sociologist right critiqu model individualist outlook insuffici distinct two anti individualist model common inform work well known sociolog model cultur influenti conceptu model tentat call finitud model insuffici awar differ etiolog caus inequ human fragil polit orient redistribut recognit under sociolog finitud model also insuffici recognit finitud model may inform ill explan rais awar exist analyt util finitud model elucid core assumpt brief review influenti text late modern health polit illustr empir util notion finitud model analyz use explain ill arthur frank kathlyn conway influenti cancer memoir themat analysi memoir produc two major find first frank conway reli finitud model claim victimhood blame blamer second seem unawar doubl edg charact model tend downplay social inequ shape health analysi reveal one sided finitud sociolog model ill explan therefor need integr anti individualist model challeng lifestyl model success | D008019;D009369 | T191;T047;T054 |
34,674,570 | rescu extracorpor life support bridg durabl left ventricular assist devic ideal time durabl assist devic implant patient end stage heart failur present intermac profil still controversi data extracorpor life support ecl bridg durabl left ventricular assist devic lvad patient limit | D015199;D006333;D006353 | T074;T047;T061;T046 |
34,674,566 | peripher infus norepinephrin avoid central venous cathet placement medic intens care unit pilot studi reduc central venous cathet cvc util reduc complic intens care unit icu norepinephrin ne tradit administ via cvc lower concentr may safe administ via peripher intraven piv line | D002405;D002406;D062905 | T058;T074;T061 |
34,674,565 | axial torsion meckel diverticulum accompani small bowel volvulus case report small bowel volvulus secondari meckel diverticulum rare delay diagnosi result disastr outcom comput tomographi conduc earli differenti diagnosi particular blind end pouch structur ct alway indic meckel diverticulum diverticulectomi without adjac partial small intestin resect standard treatment symptomat meckel diverticulum howev therapi asymptomat meckel diverticulum controversi report case year old man suffer intestin obstruct secondari small bowel volvulus caus axial torsion gangren giant meckel diverticulum diverticulectomi partial intestin resect perform | D007415;D045822;D008467 | T047;T019 |
34,674,564 | way autobiograph reflect autist adult diagnos mid late adulthood use oral histori method interview record autist adult australia life histori want better understand interviewe self reflect live interview autist research interview analys autist non autist research adult interview born formal identifi autist age year group peopl sometim refer late diagnos autist adult general much research done autist adult even less known diagnos late life articl explor adult said sens self chang time autist adult told us mani negat experi includ trauma shape think autism diagnosi posit impact sens self allow understand past feel good autist ident previous research said autist peopl limit impair sens self instead result show autist peopl actual reflect deepli live chang sens self ident time | D000067877;D001321 | T048 |
34,674,560 | multipl immunofluoresc imag analysi reveal differenti express disialogangliosid gd gd neuroblastoma peripher neuroblast tumor pnts common childhood extracrani solid tumor sever therapeut strategi target disialogangliosid gd disialogangliosid gd becom potenti target howev mechan pnts express gd gd remain unclear investig combin express status gd gd pnts delin clinicopatholog valu | D005732;D009447 | T191;T121;T109 |
34,674,557 | impact periprocedur myocardi injuri infarct definit long term mortal chronic total occlus percutan coronari intervent prognost implic biomark elev follow percutan coronari intervent pci chronic total occlus cto lesion remain controversi studi assess associ periprocedur myocardi injuri clinic relev definit periprocedur myocardi infarct subsequ outcom cto pci | D054059;D009203;D062645 | T047;T061 |
34,674,556 | balloon augment leaflet modif bioprosthet nativ aortic scallop intent lacer prevent iatrogen coronari arteri obstruct lacer anterior mitral leaflet prevent outflow obstruct benchtop valid first man experi bioprosthet nativ aortic scallop intent lacer prevent iatrogen coronari arteri obstruct basilica lacer anterior mitral leaflet prevent outflow obstruct lampoon reduc risk coronari left ventricular outflow obstruct obstruct transcathet aortic valv replac transcathet mitral valv replac despit success lacer basilica lampoon may fail prevent obstruct caus inadequ leaflet splay patient challeng anatomi small valv coronari distanc diffus calcifi rigid leaflet undergo transcathet aortic valv replac insid exist transcathet aortic valv replac describ novel techniqu balloon augment ba leaflet lacer enhanc leaflet splay | D006350;D019918;D022125;D049897;D065467 | T037;T204;T074;T061 |
34,674,555 | prognost impact pancoronari quantit flow ratio assess patient undergo percutan coronari intervent acut coronari syndrom quantit flow ratio qfr introduc novel angiographi base modal fast hemodynam assess coronari arteri lesion valid fraction flow reserv studi sought defin prognost role pancoronari qfr assess patient acut coronari syndrom ac includ postintervent culprit nonculprit vessel | D054058;D003324;D053805;D062645 | T047;T061;T201 |
34,674,554 | associ stent implant progress nontarget lesion rabbit model atherosclerosi progress nontarget lesion ntls percutan coronari intervent pci report howev remain unknown whether progress ntls causal relat stent studi undertaken test hypothesi stent implant trigger acut phase respons system inflamm may associ progress ntls | D050197;D062645 | T047;T061;T046 |
34,674,552 | preval protect haplotyp slcob gene statin transport mexican popul aim evalu genet distribut rs rs variant slcob gene mexican mestizo admix nativ american group materi method recruit volunt qpcr genotyp taqman probe result allel genotyp frequenc report among expect rs rs haplotyp preval relat normal activ oatpb transport follow g haplotyp associ statin transport cholesterol reduct conclus base slcob gene variant confirm minimum fraction mexican studi popul would risk decreas simvastatin transport develop statin induc myopathi | D019161;D009135 | T047;T121;T109 |
34,674,551 | meropenemvaborbactam activ vitro new option klebsiella pneumonia carbapenemas kpc produc klebsiella pneumonia treatment aim infect klebsiella pneumonia carbapenemas kpc produc k pneumonia repres major challeng limit treatment strategi new lactam lactamas inhibitor associ may help deal challeng aim studi evalu vitro suscept kpc produc k pneumonia meropenemvaborbactam comparison ceftazidimeavibactam materi method twenti eight strain isol blood cultur evalu test suscept meropenemvaborbactam ceftazidimeavibactam perform e test gradient strip result clinic isol suscept meropenemvaborbactam one strain resist ceftazidimeavibactam mic gml median mic ceftazidimeavibactam evalu standard higher compar meropenemvaborbactam conclus meropenemvaborbactam could import turn point treatment kpc produc k pneumonia infect especi consid emerg ceftazidimeavibactam resist | D002442;D007711;D000077731 | T195;T007;T121;T109 |
34,674,550 | clinician perspect communic implement challeng precis oncolog aim describ patient communic challeng encount oncolog clinician repres fundament barrier implement precis oncolog materi method conduct three focus group includ breast melanoma thorac oncolog clinician regard precis oncolog communic experi transcript review code use induct themat text analysi result identifi four theme vari definit precis oncolog exist clinician patient face uniqu challeng precis oncolog implement patient communic challeng engend heighten precis oncolog implement clinician communic solut train need conclus studi elucid clinician perspect implement precis oncolog relat communic challeng understand challeng develop strategi help clinician navig discuss critic ensur patient reap full benefit precis oncolog | D009369 | T191 |
34,674,548 | develop cognat awar child secondthird languag learner french french immers effect orthograph overlap cognat status purpos year longitudin studi track develop cognat awar among second l third languag l learner french french immers grade explor impact orthograph overlap cognat status true vs fals children abil recogn cognat relationship also assess impact french status perform method compar perform three condit true cognat similar spell fals cognat spell within across grade use direct measur cognat awar requir children n distinguish true fals cognat present oral print result overal grade children fail recogn cognat relationship true cognat similar spell success recogn true cognat spell perform condit increas signific grade greatest improv seen true cognat similar spell perform fals cognat inferior perform true cognat spell grade inferior perform similar spell true cognat grade differ found due status conclus among sequenti learner french earli stage addit languag learn cognat awar impact degre orthograph overlap well cognat status children abil recogn cross languag orthograph semant relationship improv substanti across earli elementari grade supplement materi https doiorgasha | D007802;D019303 | T171 |
34,674,547 | autoimmun diseas hiv negat cryptococc mening aim purpos studi assess differ hiv negat cryptococc mening cm patient without autoimmun diseas method total cm patient autoimmun diseas without autoimmun diseas enrol analysi result cm patient autoimmun diseas higher fever modifi rankin scale score c reactiv protein erythrocyt sediment rate lower rate visual hear symptom ventriculoperiton shunt mri mening enhanc amphotericin b treatment well lower cerebrospin fluid pressur fungal count divid accord gender group lower intracrani pressur higher inflamm indic differ outcom sequela mortal hazard found fluconazol treatment prognost factor cm without autoimmun diseas conclus antifung anti inflammatori therapi consid cm patient autoimmun diseas | D001327;D016919 | T047 |
34,674,546 | character standard multiassay platform four common studi traumat brain injuri protein biomark tbi endpoint develop studi aim critic need valid biofluid base biomark diagnost drug develop tool traumat brain injuri tbi part tbi endpoint develop initi identifi four potenti predict pharmacodynam biomark tbi astrogli marker gfap sb neuron marker uch l tau materi method sever common use platform four biomark identifi compar analyt perform abil detect gold standard recombin protein antigen pool control versus tbi cerebrospin fluid csf result marker assay format could differenti tbi csf control csf also differ assay biomark report diverg biomark valu biosampl conclus due variabl tbi marker assay perform report valu standard strategi recommend compar report biomark level across assay platform | D023381 | T062 |
34,674,545 | phonolog develop urdu speak children systemat review background speech languag research studi phonolog acquisit evalu error children make understand complex process inform provid clinician scientif refer better assess intervent servic children articulationphonolog disord urdu languag spoken million speaker worldwid howev research urdu phonolog develop infanc purpos systemat review aim identifi relev studi provid comprehens review aspect urdu phonolog develop target along report find method five phase prefer report item systemat review meta analys guidelin follow retriev studi publish januari march focus urdu speech sound acquisit andor phonolog process typic develop nativ urdu speaker age year includ review final search conduct may result total record identifi five databas manual search nine studi fulfil inclus criteria includ final review studi publish english languag five unpublish master these four peer review journal articl four studi focus conson acquisit wherea five explor phonolog process studi focus acquisit urdu vowel diphthong conson cluster shortlist studi review detail determin particip demograph characterist focus area phonolog acquisit data elicit method context transcript system major find conclus studi provid comprehens review avail literatur urdu phonolog develop highlight area futur research | D007802;D010700 | T068;T171;T090 |
34,674,542 | joint model longitudin marker time event outcom applic tutori patient surgic repair transposit great arteri patient congenit heart diseas surviv adulthood howev residu abnorm remain manag patient life long person patient surgic repair transposit great arteri exampl face risk develop neoaortic valv regurgit cardiologist updat prognosi patient intuit updat inform cardiovascular status patient instanc echocardiograph imag | D001022;D014188 | T047;T019 |
34,674,541 | compar studi mental health impact covid pandem health care profession india aim studi aim investig psycholog health health care profession hcp covid duti differ direct contact methodolog random select respond doctor nurs whatsapp request messag subject data final analyz result preval stress anxieti depress among hcp respect compar nonexpos profession covid expos profession rough doubl score morbid p p p worri health famili follow conclus level exposur feel uncertainti fear infect emerg studi possibl risk factor psycholog morbid among hcp | D000086382;D008603 | T047;T041;T067 |
34,674,540 | word fluenci test perform primari progress aphasia primari progress apraxia speech purpos studi compar perform three word fluenci measur among individu primari progress aphasia ppa primari progress apraxia speech ppao examin relationship word fluenci measur languag speech method studi includ adult ppa adult ppao ppa particip divid three clinic subgroup semant svppa logopen lvppa nonfluentagrammat without apraxia speech nfppa categori fluenci letter fluenci actionverb fluenci task administ particip result four clinic group perform abnorm word fluenci measur although degre repres high sensit ppa ppao diagnosi ppa subgroup produc fewer word compar individu ppao word fluenci measur moder correl found word fluenci aphasia sever name perform clinic group conclus word fluenci measur often challeng individu ppa ppao equal difficulti letter fluenci difficult differ among word fluenci test also vari degre function clinic group question least impair ppao howev find studi support statist signific differ word fluenci task perform among ppa subgroup correl suggest word fluenci perform ppa least part relat aphasia sever | D018888;D001072 | T048;T047;T046 |
34,674,538 | applic fourier transform infrar spectroscopi real time type acinetobact baumannii outbreak intens care unit aim acinetobact baumannii pathogen serious concern often exhibit multipl antibiot resist frequent associ hospit outbreak intens care unit prompt detect track isol crucial refer method type puls field gel electrophoresi whole genom sequenc accur expens time consum therefor limit retrospect analysi materi method studi applic ftir base ir biotyp irbt track monitor real time spread multidrug resist baumannii outbreak investig index case multidrug resist baumannii isol collect follow week investig result ir biotyp cluster result fulli confirm puls field gel electrophoresi result conclus ir biotyp repres promis tool real time hospit hygien enabl prompt reliabl type | D040981;D017550 | T007;T059 |
34,674,537 | talk therapi someon ca nt talk perspect mental health provid deliv servic individu aphasia purpos aphasia correl depress anxieti negat impact qualiti life aphasia also frequent misunderstood among mental health care provid aim studi explor experi mental health provid provid servic peopl live aphasia method interpret phenomenolog analysi use analyz interview six mental health provid experi provid servic peopl aphasia result three main theme among mental health care provid experi provid servic peopl aphasia identifi barrier interprofession collabor therapi look differ subthem associ barrier includ insuffici train knowledg aphasia stigma receiv mental health servic access servic subthem relat interdisciplinari collabor includ referr knowledg awar strategi tool subthem support therapi look differ includ new approach therapi challeng conclus mental health provid experi reveal need action orient approach overcom barrier nontradit approach talk therapi peopl aphasia increas collabor speech languag pathologist slps futur research explor expand collabor slps mental health provid increas share knowledg skill issu relat reduc depress anxieti support well peopl aphasia | D001037;D003147;D008605 | T058;T048;T047 |
34,674,535 | result survey aim dietitian nutritionist manag clinic nutrit team covid pandem hospit catalonia introduct covid pandem direct implic clinic nutrit team nt organiz healthcar level sinc march expert recommend nutrit intervent patient covid avail object describ nutrit intervent carri patient covid estim presenc clinic dietitian nutritionist dn hospit catalonia know organ nts method cross section studi onlin survey direct clinic dns hospit catalonia march made result survey nts made dns analys total nts interrupt reduc usual activ pandem nutrit screen use carri earli h case common tool nrs nts specif hospit diet establish general hyperprot oral nutrit supplement systemat prescrib nts priorit hyperprot hypercalor formula estim clinic dns present approxim public acut hospit catalonia conclus result reflect adapt capac nts reorgan redistribut usual task establish infrequ measur ensur nutrit support | D058873 | T067 |
34,674,534 | context histor correl origin develop oldest continu exist residenti alcohol treatment model apolinar model central europ build upon tradit oldest special program apolinar model alcohol treatment influenc emerg develop residenti treatment program czech republ slovakia similar socialist concept unitari economi approach appli emerg treatment program velvet revolut identifi describ key factor determin origin develop residenti alcohol treatment becam known apolinar model context develop addict specif institut infrastructur qualit content analysi retriev histor document use identifi establish sourc data relev document identifi compil accord themat relationship focus research term place time origin authorship apolinar model repres compact uniqu treatment approach owe foreign local experi idea inspir program drew key figur behind apolinar model jaroslav skla addit achiev maximum possibl time creat homogen origin success residenti alcohol treatment model skla succeed establish valuabl intern link kept facil emerg czechoslovak addict profession communiti contact latest intern trend lead institut | D012114 | T061 |
34,674,533 | modern trend manag complic gastrointestin ostomi stoma format import compon mani surgic procedur perform wide rang disord gastrointestin tract ostomi relat complic remain common associ signific morbid well cost st centuri stoma patient care dynam develop field medicin worldwid pouch system product focus differ physic profil popul regard inequ abdomin wall skin lash mani case caus leakag pouch system underflow stoma effluent underneath ostomi devic result peristom skin complic clear trend care patient inequ abdomin wall toward product distribut convex ostomi pouch system convex system differ size depth patient ileostomi colostomi avail market way enterostom therapist possibl use adequ pouch system soft mild deep convex system author review common local complic stoma creation detail measur prevent outlin recommend manag includ nurs procedur stoma therapist | D010030;D054047 | T017;T061 |
34,674,532 | use select poct method general practition czech republ point care test allow effect rapid diagnosi acut condit better manag chronic diseas ration use prescrib medicin use select non mandatori test analys relat avail across urban rural general medic practic czechia data obtain largest health insur compani czechia categoris differ type surgeri spatial model creat appli oecd region typolog primari care czechia intern normalis ratio inr common avail test acut care c reactiv protein crp test extens present practic though surgeri perform test inr crp account wherea use least one contract haemoglobin ac amount practic contract perform three test report usag around half general practition czechia contract provid popular non mandatori point care test report usag differ among various surgeri typolog peripher surgeri report higher rate | D058005 | T097 |
34,674,531 | factor influenc end life decisionmak process care hospit patient qualiti end life care hospit patient import topic far littl explor czech republ aim studi map factor influenc end life care decis make process select czech hospit describ base data medic record perspect doctor research includ data obtain medic record deceas patient mean age year women research sampl medic doctor comment decis make end life care patient consist physician mean age year women result point persist defici written record care goal prognosi possibl decis limit care medic doctor limit health care primarili base consensus among physician patient usual invit decis make process patient prefer end life period case ascertain question postpon institut previous state wish appear examin group conclud decis end life care usual take place without knowledg patient valu prefer result indic need improv train doctor medic student addit build profession compet includ train effect communic patient end life | D010820;D013727 | T097;T058 |
34,674,530 | antibodi previous infect bring suffici long term protect covid one basic manifest adapt anti infect immun product specif antibodi presenc antibodi detect serum serv one diagnost tool use confirm past infect often also serv confirm bodi acquir immun diseas appear covid cast shadow doubt textbook exampl antibodi behavior inform repeat question antibodi measur signific circul among profession general public aim articl summar current knowledg immun acquir follow sar cov infect present result antibodi test four czech laboratori measur antibodi one year data suggest common avail diagnost method reliabl predict result virus neutral test gold standard immun detect acknowledg natur acquir anti infect immun addit vaccin individu signific increas perceiv level collect immun | D000086382 | T047;T067 |
34,674,527 | modul insulin aggreg charg variabl cholic acid deriv polym understand effect cholic acid ca base charg variabl polymer architectur modul insulin aggreg process herein design side chain cholat contain charg variabl polym three differ type copolym methacryloyloxi ethyl cholat anion cation neutral unit synthes revers addit fragment chain transfer polymer effect copolym insulin fibril process studi multipl biophys approach includ differ type spectroscop microscop analys interest ca base cation polym cp observ inhibit insulin fibril process dose depend manner act effect anti amyloidogen agent correspond anion ap neutral np copolym cholat pendant remain insignific control aggreg process tyrosin fluoresc assay nile red fluoresc measur demonstr role hydrophob interact explain inhibitori potenc cp furthermor circular dichroism spectroscop measur carri explor secondari structur chang insulin fibril presenc cation polym without cholat moieti isotherm titrat calorimetri measur reveal involv electrostat polar interact ca base cation polym insulin differ stage fibril overal work demonstr efficaci ca base cation polym control insulin aggreg process provid novel dimens studi protein aggreg | D007328;D011108 | T116;T121;T104;T125;T122 |
34,674,526 | structur stabil insulin oligom protein associ dissoci process free energi landscap univers role water associ dissoci protein import biochem event featur articl analyz avail studi process insulin oligom aqueous solut focus solvat insulin monom water stabil dissoci dimer structur integr hexam intric role water solvat dimer hexam form surfac long rang interact monom stabil oligom discuss ten water molecul insid central caviti stabil structur insulin hexam discuss differ order paramet use understand dissoci insulin dimer calcul rate use recent comput multidimension free energi provid consider insight interplay protein water dynam | D007328;D014867 | T116;T121;T197;T125 |
34,674,525 | redox activ moieti dissolv organ matter acceler degrad nitroimidazol base oxid presenc dissolv organ matter dom known inhibit degrad trace organ contamin troc base advanc oxid process aop due filter photochem activ light radic scaveng effect studi reveal unexpect contribut dom degrad nitroimidazol nzs uvpersulf aop appar second order rate constant nzs increas time presenc differ dom increment linear relat total electron capac dom quinon polyphenol moieti found play domin role reactiv speci generat oxid dom includ semiquinon radic sq superoxid found react nzs via michael addit addit second order rate constant tinidazol sq determin laser flash photolysi reactiv speci potenti generat dom may consid design process abat differ type troc | D009593;D014874 | T131;T121;T109 |
34,674,521 | pattern multimorbid older adult implic nongeriatrician specialist multimorbid recogn import factor geriatr medicin howev import specialist still fulli appreci | D008659;D000076322 | T047;T078 |
34,674,520 | ultrasound predictor left adren metastasi patient lung cancer comparison comput tomographi positron emiss tomographi comput tomographi endoscop ultrasound use ultrasound bronchoscop patient resect lung cancer requir invas evalu enlarg left adren gland lag studi show util endoscop ultrasound use ultrasound bronchoscop eusb lag assess moreov littl known combin comput tomographi ct positron emiss tomographi comput tomographi petct eusb predict left adren metastasi | D008175;D000072078 | T191;T060 |
34,674,515 | heart rate variabl follow covid case report detect earli increas inflammatori respons might prove vital mitig deleteri effect diseas time | D000086382;D000076251 | T047;T073;T067 |
34,674,513 | approach quantifi hepat b virus coval close circular dna chronic hepat b major caus liver diseas worldwid current incur hepat b virus hbv coval close circular ccc dna key form virus respons persist transcript templat viral transcript field focuss method clear hbv cccdna limit technic difficulti quantif due ident sequenc form hbv dna low copi number per cell high resist denatur heat lead difficulti use polymeras chain reaction hybrid method detect number assay develop order overcom hurdl either direct detect cccdna level indirect via transcript product review summar approach cccdna quantif current use outlin key open question cccdna biolog field remain answer due limit current method | D006509;D019694 | T047 |
34,674,511 | musclin relat insulin resist bodi composit bodi mass index cardiorespiratori capac adult studi whether musclin function human relat glycem control bodi composit cardiorespiratori capac | D007333 | T046 |
34,674,510 | chang insulin resist index risk liver fibrosi patient nonalcohol fatti liver diseas without diabet kangbuk samsung health studi fibrosi import prognost factor nonalcohol fatti liver diseas nafld insulin resist play key role fibrosi progress evalu associ chang homeostasi model assess insulin resist homa ir valu chang fibrosi status nafld | D003920;D007333;D065626 | T047;T046 |
34,674,509 | applic machin learn bone miner research unpreced era overwhelm volum medic data machin learn promis tool may shed light individu approach better understand diseas field osteoporosi research similar research field review aim provid overview latest studi use machin learn address issu main focus osteoporosi fractur machin learn model diagnos classifi osteoporosi detect fractur imag shown promis perform fractur risk predict anoth promis field research studi conduct use various data sourc howev approach may bias due natur techniqu qualiti data therefor studi base propos guidelin need improv technic feasibl generaliz artifici intellig algorithm | D001185;D010024 | T047;T066;T073;T090 |
34,674,508 | metabol subtyp adren tumor prospect multi center cohort studi korea convent diagnost approach adren tumor requir multi step process includ imag studi dynam hormon test therefor studi aim discrimin adren tumor singl blood sampl base combin liquid chromatographi mass spectrometri lc ms machin learn algorithm serum profil adren steroid | D000310;D003480 | T191;T047 |
34,674,506 | review updat risk factor prevent antiresorpt relat osteonecrosi jaw antiresorpt relat osteonecrosi jaw aronj rare serious advers event bisphosphon denosumab administr associ sever pain deterior qualiti life sinc first report mani studi definit epidemiolog pathophysiolog diagnosi treatment nevertheless epidemiolog mechan under condit yet fulli delin sever risk factor known moreov effect treatment current avail osteonecrosi jaw prevent essenti furthermor close cooper prescrib physician dentist import aim review provid date inform regard risk factor prevent aronj physician perspect | D059266;D050071 | T047;T121;T046 |
34,674,505 | prognost valu triglycerid glucos index incid type diabet beyond metabol health obes metabol healthi obes mho phenotyp metabol heterogen term type diabet td previous triglycerid glucos tyg index consid identifi metabol health futur risk td studi aim evalu risk incid td accord obes status metabol health categor four differ criteria tyg index | D003924 | T047 |
34,674,504 | adren venous sampl subtyp diagnosi primari hyperaldosteron adren venous sampl av key procedur later primari hyperaldosteron pa surgeri identif adren vein use comput tomographi ct intraop cortisol assay facilit success catheter although administr adrenocorticotrop hormon acth benefit improv success rate unilater case could fals diagnos bilater select index acth stimul assess select catheter later index li acth stimul unilater diagnosi use mani center co secret cortisol tumor potenti affect later li patient age year hypokalemia mark aldosteron excess unilater adren nodul ct higher probabl unilater diseas patient normokalemia mild aldosteron excess adren tumor ct higher probabl bilater diseas although method specif subtyp diagnosi would allow bypass av predict subtyp consid recommend av patient methodolog standard strict indic improv diagnost qualiti av develop non invas imag biochem marker drive paradigm shift clinic practic pa | D000310;D006929 | T191;T047 |
34,674,503 | cardiovascular outcom obes accord menopaus status nationwid popul base studi estim effect obes incid cardiovascular diseas cvd mortal women accord menopaus status | D009765;D050177 | T033;T047 |
34,674,502 | deiodinas three type thyroid hormon deiodin reaction thyroid hormon th signal strict regul iodothyronin deiodinas activ preserv circul level biolog activ triiodothyronin regul th homeostasi local level cell time depend manner three deiodinas identifi name iodothyronin deiodinas dio dio dio differ catalyt properti tissu distribut deiodinas repres dynam system chang differ stage life accord function role various cell type tissu deiodinas activ tissu level permit cell target fine regul th homeostasi mediat activ dio dio inactiv dio ths deiodinas homeostasi drive forc lead target cell toward custom th signal take account hormon circul level tissu specif respons review analyz complex role deiodinas physiolog patholog context explor new challeng opportun deriv deeper knowledg dynam under role function | D007453;D013963 | T116;T126;T125 |
34,674,501 | comparison korean vs american thyroid imag report data system malign risk assess indetermin thyroid nodul manag cytolog indetermin thyroid nodul challeng clinician studi aim compar diagnost perform korean thyroid imag report data system k tirad american colleg radiolog acr tirad predict malign risk indetermin thyroid nodul | D013964;D016606 | T191 |
34,674,500 | associ thyroid function heart rate monitor wearabl devic patient hypothyroid heart rate hr monitor wearabl devic wd demonstr clinic feasibl thyrotoxicosi subject howev associ hr monitor wearabl hypothyroid examin assess associ serum thyroid hormon concentr three wd hr paramet hypothyroid subject | D007037;D013964;D000076251 | T191;T047;T073 |
34,674,499 | frequenc exposur impair fast glucos risk mortal cardiovascular outcom metabol abnorm impair fast glucos ifg dynam phenomena howev unclear whether time ifg exposur cumul exposur ifg relat cardiovascular diseas cvd mortal risk | D009203;D011236 | T047 |
34,671,456 | covid measur human right guarante japanes constitut sinc march act special measur pandem influenza new infecti diseas prepared respons signific statut deal covid japan act mandat request instruct order busi suspens shorten busi hour well stay home request measur limit freedom movement establish guarante right japanes constitut articl pose follow research question japanes constitut allow measur covid request instruct order busi suspens shorten busi hour stay home request also ask measur penalti allow constitut given fact penalti introduc februari paper introduc constitut concept guarante limit individu freedom concept guarante individu freedom includ freedom establish movement freedom deriv constitut valu freedom choos one occup choos chang one resid art right hold properti art concept limit individu freedom includ right life art welfar right public health art public welfar art individu freedom threaten right life welfar right public health public welfar may guarante paper argu constitut allow measur covid limit freedom establish movement perspect right life welfar right public health public welfar govern respons reduc risk life covid also argu constitut permit measur penalti proport need consid | D000086382 | T047;T067 |
34,674,470 | advanc clinic applic obstruct cathet prevent treatment intestin obstruct intestin obstruct one common diseas abdomin surgeri prevent treatment clinic difficulti although surgic oper solv symptom obstruct mani postop complic easi develop obstruct due postop abdomin adhes intern fixat small intestin obstruct cathet provid new idea prevent postop adhes bowel obstruct use transan ileus cathet provid possibl direct intestin anastomosi resect malign obstruct left hemicolon reduc incid postop complic howev suffici attent paid relat complic prevent treatment plan import note use obstruct cathet one conserv treatment bowel obstruct complet replac surgeri surgic treatment still consid cathet fail signific move obstruct symptom signific improv day catheter | D013505;D007415 | T047;T061 |
34,674,469 | research progress sexual dysfunct follow rectal cancer surgeri sexual dysfunct incid common postop complic rectal cancer ratio men women similar sexual function innerv abdomin pelvic autonom nerv differ sexual dysfunct caus differ part degre injuri autonom nerv oper rectal cancer develop pelvic autonom nerv preserv rectal cancer radic resect postop sexual function protect may mani factor increas incid postop sexual dysfunct rectal cancer postop psycholog factor stoma abdomin perin resect radiotherapi effect laparoscop surgeri robot surgeri transan total mesorect excis later lymph node dissect postop sexual function remain controversi base multidisciplinari cooper model attent paid psycholog intervent patient partner clinic practic male use phosphodiesteras inhibitor vacuum erectil devic inject vasodil peni urethra femal local applic estrogen lubric vagina effect treatment postop sexual dysfunct rectal cancer addit stem cell therapi promis prospect sexual dysfunct | D010535;D012004;D012735 | T061;T191;T046;T060 |
34,674,468 | advanc challeng neoadjuv treatment colorect cancer liver metastasi liver metastasi lead caus death patient colorect cancer sinc surgic resect alon high postop recurr rate neoadjuv therapi import mean wide appli order reduc recurr improv surviv progress achiev mani aspect neoadjuv therapi colorect cancer liver metastasi elig patient select optim regimen cours chemotherapi howev controversi still remain regard standard resect lesion applic target drug individu treatment could develop base multidisciplinari teamwork achiev goal resourc integr treatment stratif | D015179;D008113 | T191 |
34,674,467 | biolog mesh versus primari closur pelvic floor reconstruct follow extralev abdominoperin excis meta analysi object compar morbid perineum relat complic biolog mesh primari closur close pelvic floor defect follow extralev abdominoperin excis elap method literatur search perform pubm embas cochran librari web scienc wanfang databas chines nation knowledg infrastructur vip databas china biolog medicin databas publish clinic research perineum relat complic follow elap januari august literatur inclus criteria studi subject patient undergo elap rectal cancer confirm colonoscopi patholog biopsi surgic patholog studi type random control studi observ studi compar postop perineum relat complic two group primari perin closur reconstruct biolog mesh follow elap intervent measur biolog mesh reconstruct use treatment group primari closur use control group outcom measur includ literatur least includ one follow postop perin complic overal perin wound complic perin wound infect perin wound dehisc perin hernia chronic sinus chronic perin pain postop month urinari dysfunct sexual dysfunct literatur exclus criteria data publish repeat studi incomplet wrong origin data unabl obtain origin data two review independ perform screen data extract assess qualiti includ studi review manag softwar use meta analysi mobid perineum relat complic includ overal perin wound infect dehisc hernia chronic sinus perin chronic pain postop month compar two pelvic floor reconstruct method final public bias assess sensit analysi use evalu stabil result result total five studi includ two random control studi three observ control studi patient case biolog mesh group case primari closur group final includ compar primari closur biolog mesh reconstruct signific lower ratio perin hernia rr ci p conclus compar primari closur pelvic floor reconstruct follow elap biolog mesh advantag lower incid perin hernia | D010502;D000078542 | T029;T061 |
34,674,466 | efficaci print fistula stent treatment enteroatmospher fistula object investig efficaci fistula stent made print techniqu treatment enteroatmospher fistula method descript case seri studi carri | D034861;D007412 | T190;T047;T023 |
34,674,465 | comparison clinic efficaci bursa omentali approach medial later approach laparoscop left hemicolectomi propens score match analysi object splenic flexur mobil technic difficult resect left hemicolon cancer studi aim compar safeti effect bursa omentali approach boa medial later approach mtla laparoscop radic resect left side colon cancer method retrospect cohort studi conduct inclus criteria patient underw radic resect left hemicolon cancer postop patholog result adenocarcinoma patient age year old liver periton distant metastasi exclus criteria poor physic condit serious heart brain lung liver kidney hematopoiet system diseas unabl toler laparoscop surgeri histori malign simultan multisourc tumor emerg oper due bleed obstruct perfor etc clinic data patient underw laparoscop left hemicolectomi guangdong provinci hospit chines medicin retrospect analyz accord surgic approach patient divid boa group case mtla group case whole group patient match propens score match psm accord nearest neighbor match method calip valu match variabl includ gender age american societi anesthesiologist asa score bodi mass index tumor locat tumor stage psm patient includ boa group mtla group respect signific differ baselin data two group psm p pair test pair rank sum test pair chi squar test use compar intraop postop parameth two group kaplan meier method use draw surviv curv log rank test use inter group comparison two surviv curv intersect two stage method restrict mean surviv time rmst perform result group patient success complet oper without convers laparotomi intraop death combin splenectomi pancreatectomi perform two group also signific differ intraop blood loss number harvest lymph node time first flatus length hospit stay two group p howev median laparoscop dissect time boa group shorter mtla group differ statist signific median minut vs minut p entri posterior pancreat space record boa group wrong entri posterior pancreat space happen patient bodi mass index kgm dissect left toldt fascia mtla group year diseas free surviv rate boa group mtla group respect p year overal surviv rate respect p conclus boa safe feasibl laparoscop left hemicolectomi especi inexperienc surgeon obes patient boa facilit entranc correct anatom level avoid enter retropancreat space | D010535 | T061;T060 |
34,674,464 | thirti year chang strategi later lymph node dissect low rectal cancer treatment experi prognost analysi case one singl center object surgic indic resect extent manag principl later lymph node dissect llnd lower rectal cancer controversi eastern western countri studi aim provid theoret basi ration implement llnd review chang llnd strategi past year singl center analyz prognost factor surviv outcom patient later lymph node metastasi llnm method retrospect observ studi perform clinic data patient rectal cancer receiv llnd depart general surgeri peke univers first hospit collect patient divid three group base decad case group case group case group data analyz patient baselin data surgeri postop recoveri later lymph node dissect postop surviv prognosi patient posit later lymph node surgic method patholog result llnd compar group prognost risk factor patient llnm analyz result total patient underw radic resect llnd account patient rectal cancer period hospit except decad decad increas tumor distanc anal verg cm proport ulcer tumor proport neoadjuv radiochemotherapi differ baselin data statist signific among decad group p proport llnd group decreas decad decad vs vs p proport laparoscop surgeri unilater llnd increas mean oper time intraop blood loss surgic complic grade iii postop hospit stay decreas decad decad patient complet total later dissect includ case unilater dissect case bilater dissect proport llnd group decreas decad decad vs vs p median number dissect lymph node intern iliac arteri obtur region increas vs vs p common iliac extern iliac region decreas signific vs vs p total patient llnm identifi rate llnm group signific higher previous two group vs vs p patient llnm show poorer overal surviv os diseas free surviv dfs compar negat later lymph node p statist signific differ year os rate vs vs p year dfs rate vs vs p among patient intern iliac lymph node metastasi patient obtur lymph node metastasi patient extern iliac common iliac lymph node metastasi multivari analysi prognost factor show extern iliac common iliac lymph node metastasi independ risk factor os hr ci dfs hr ci patient llnm p os dfs signific differ patient llnm among decad group conclus past decad proport llnd rectal cancer decreas signific howev llnm rate signific increas due preoper imag assess focus suspici llnm without compromis surviv intern iliac arteri obtur lymph node regard region lymph node satisfactori prognosi llnd suspect extern iliac common iliac lymph node metastasi signific llnd remain evalu | D008197;D012004 | T191;T061 |
34,674,463 | establish valid nomogram predict overal surviv patient gastric neuroendocrin neoplasm object establish novel nomogram predict overal surviv patient gastric neuroendocrin neoplasm g nen method case control studi conduct clinicopatholog follow data patient g nen treat two academ medic center southern china juli june retrospect collect includ patient sun yat sen univers cancer center patient first affili hospit sun yat sen univers univari surviv analysi use kaplan meier method multivari analysi use cox regress perform identifi prognost factor nomogram subsequ establish base prognost factor harrel concord index c index receiv oper characterist roc curv calibr curv decis curv analysi dca use verifi perform model accord differenti calibr clinic util result total patient enrol studi patient male femal age diagnosi year old patient year older patient patient diagnos gastric neuroendocrin carcinoma g nec patient gastric neuroendocrin tumor g net number patient primari tumor locat upper middl lower part stomach respect tnm stage patient categor stage patient stage ii patient stage iii patient stage iv univari analysi indic age patholog type primari site ki index stage n stage stage associ overal surviv g nen patient p multivari regress analysi testifi high ki index advanc stage advanc stage independ prognost factor p c index nomogram ci calibr curv nomogram show predict surviv rate consist actual surviv rate g nen patient roc curv dca show nomogram better differenti clinic util american joint committe cancer ajcc th tnm stage system area roc curv vs conclus first nomogram predict overal surviv patient g nen establish verifi studi provid individu predict year overal surviv rate applic g net g nec patient | D018358;D049451 | T191;T170;T081 |
34,674,462 | comparison clinic characterist sporad gastrinoma multipl endocrin neoplasia type relat gastrinoma object compar clinic characterist sporad gastrinoma multipl endocrin neoplasia type men relat gastrinoma method retrospect cohort studi conduct patient clinic manifest zolling ellison syndrom patholog diagnosi neuroendocrin neoplasm nen complet clinic follow data enrol patient high gastric acid secret without evid nen concurr non nen tumor exclud accord criteria clinicopatholog data case gastrinoma diagnos april decemb first affili hospit sun yat sen univers collect patient met diagnost criteria gastrinoma met one follow condit diagnos men relat gastrinoma presenc pathogen mutat men gene confirm genet test nen involv two endocrin gland name pituitari parathyroid thymic pancreat adren nen nen least one first degre relat diagnos men remain gastrinoma defin sporad gastrinoma student test chi squar test use statist analysi clinicopatholog characterist endoscop find imag characterist treatment prognosi sporad men relat gastrinoma compar result among patient gastrinoma sporad gastrinoma men relat gastrinoma common symptom sporad men relat gastrinoma diarrhea abdomin pain compar sporad gastrinoma men relat gastrinoma need longer time diagnosi year vs year p like multipl tumor vs p smaller diamet cm vs cm p present lower tumor grade g vs g vs g vs z p less like serum gastrin time higher normal vs p higher probabl complic type gastric neuroendocrin tumor g net vs p lower rate liver metastasi vs p obvious differ sporad gastrinoma men relat gastrinoma endoscop find type present enlarg swollen gastric mucosa stimul high gastric acid multipl ulcer stomach duodenum could seen gastrinoma type g net present multipl polypoid rais lesion fundus bodi stomach ga ssr petct scan detect rate type f fdg petct scan higher detect rate sporad gastrinoma compar men relat gastrinoma vs p among patient sporad gastrinoma receiv surgic treatment underw endoscop submucos dissect underw transcathet arteri embol tae underw surgeri combin tae among patient men relat gastrinoma receiv surgic treatment receiv conserv treatment median follow patient month year surviv rate year surviv rate patient sporad men relat gastrinoma respect p year surviv rate patient without liver metastasi vs respect p conclus compar sporad gastrinoma men relat gastrinoma longer diagnosi delay smaller tumor diamet lower tumor grade lower risk liver metastasi like complic type g net differ surviv two tumor type | D015408;D018761;D010190 | T191 |
34,674,461 | advanc basic translat research neuroendocrin neoplasm develop diagnost techniqu improv peopl live standard detect rate neuroendocrin tumor increas peopl pay attent multipl treatment modal clinic research progress neuroendocrin tumor remark howev due tumor heterogen metastasi recurr neuroendocrin tumor remain difficult problem clinician efficaci neuroendocrin tumor still need improv therefor biolog behavior neuroendocrin tumor need studi recent year develop molecular biolog basic transform research neuroendocrin tumor made progress paper focus hot topic neuroendocrin tumor multiom copi number variat genom transcriptom tumor microenviron immun microenviron tumor microvasculatur tumor associ fibroblast etc preclin research model construct cell line organoid patient deriv xenograft model genet engin mice etc specif relat clinic transform signific elabor | D018358;D057170 | T191;T062 |
34,674,460 | advanc immunotherapi neuroendocrin neoplasm neuroendocrin neoplasm nen rare heterogen tumor differ patholog morpholog differenti grade clinic stage tumor various treatment prognosi patient recurr metastat nen limit treatment option poor prognosi recent year pd pathway blockad becom integr compon diseas manag mani cancer immunotherapi explor nen studi shown efficaci immun monotherapi nen limit consid select patient biomark predict efficaci immunotherapi includ pd l express tmb h msi hdmmr etc combin regimen anti ctla anti pd pd l inhibitor immun checkpoint inhibitor combin anti angiogen drug chemotherapi promis patient nen worthwhil explor respond popul | D009369;D018358 | T191 |
34,674,459 | endoscop diagnosi treatment gastrointestin neuroendocrin neoplasm incid neuroendocrin neoplasm nen increas global gastrointestin nen gi nen common type nen diagnosi treatment gi nen quit differ accord tumor locat size background cell origin pathogenesi digest endoscopi uniqu advantag detect gi nen howev endoscopist perform endoscop resect arbitrarili due high heterogen complex gi nen need establish concept comprehens assess gi nen includ medic histori physic sign serolog imag radionuclid endoscop examin make individu treatment rigor multidisciplinari discuss | D005770;D018358 | T191 |
34,674,458 | surgic treatment gastric neuroendocrin neoplasm neuroendocrin neoplasm nen rare neoplasm origin major system gastric neuroendocrin neoplasm g nen rare malign neoplasm origin stomach th classif digest system tumor updat classif g nen solv sever name problem sinc classif g nen becom specif scientif surgic treatment g nen becom individu precis general endoscop resect often recommend treatment type gastric neuroendocrin tumor net type ii gastric net most secondari gastrinoma origin duodenum pancrea thus surgic treatment primari gastrinoma deserv enough attent decis oper type iii gastric net need comprehens consider tumor size invas depth lymph node metastasi gastric neuroendocrin carcinoma without distant metastasi aggress surgeri perform resect rang primari site lymph node refer standard gastric adenocarcinoma local advanc gastric nec report whether neoadjuv chemotherapi neoadjuv chemoradiotherapi could reduc tumor stage improv radic resect rate addit function gastric nen distant metastasi radic resect palliat surgeri perform control hormon secret may improv surviv general import principl thorough consid biolog behavior extent primari metastat site resect function tumor surgeri gastric neuroendocrin neoplasm thus multi disciplinari treatment mdt recommend | D018278;D005770;D018358;D013274 | T191 |
34,674,457 | interpret updat intern guidelin diagnosi treatment gastroent opancreat neuroendocrin neoplasm incid neuroendocrin neoplasm nen continu increas gastrointestin tract pancrea common primari site current guidelin propos european neuroendocrin tumor societi enet nation comprehens cancer network nccn european societi medic oncolog esmo north american neuroendocrin tumor societi nanet wide appli among enet nanet guidelin propos esmo nccn recent updat guidelin gastroenteropancreat nen respect articl interpret diagnosi treatment gastroenteropancreat nen base newli updat esmo nccn guidelin diagnosi gastroenteropancreat nen depend histolog assess includ morpholog evalu grade immunohistochemistri result combin differ imag method help determin tumor stage risk assess decis make treatment follow strategi base primari tumor site tumor classif tumor grade tumor type function status etc | D005770;D018358 | T191 |
34,674,447 | research progress cell senesc cardiac remodel | D006321;D020257 | T023;T042 |
34,674,446 | clearanc senesc cell novel treatment strategi attenu age associ cardiovascular diseas dna | D002318;D002319 | T022;T047 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.